NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Bausch And Lomb	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	dexamethasone; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	064063	ANDA	Bausch & Lomb Incorporated	24208-795-35	1 TUBE in 1 CARTON (24208-795-35) / 3.5 g in 1 TUBE	1994-07-25
Bausch And Lomb	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	dexamethasone; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	064063	ANDA	A-S Medication Solutions	50090-6181-0	1 TUBE in 1 CARTON (50090-6181-0) / 3.5 g in 1 TUBE	1994-07-25
Bausch And Lomb	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	dexamethasone; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	064063	ANDA	Proficient Rx LP	63187-669-35	1 TUBE in 1 CARTON (63187-669-35) / 3.5 g in 1 TUBE	1994-07-25
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 28, 2025

ppliers for the Pharmaceutical Drug: Neomycin and Polymyxin B Sulfates and Dexamethasone

Introduction

The combination of Neomycin, Polymyxin B Sulfates, and Dexamethasone is a widely used ophthalmic formulation aimed at treating bacterial infections and reducing inflammation in ocular disorders. As demand for this compound rises globally, a comprehensive understanding of its primary suppliers is crucial for pharmaceutical companies, healthcare providers, and regulatory bodies to ensure drug quality, supply chain stability, and compliance with international standards.

Market Overview and Importance of Reliable Suppliers

This fixed-dose combination offers both antimicrobial activity and anti-inflammatory effects, making it a vital component in ophthalmic therapeutics. The complexity of synthesizing and formulating these compounds necessitates sourcing from reputable suppliers with proven manufacturing capabilities, robust quality control measures, and compliance with regulatory regimes such as FDA, EMA, and other authorities.

The procurement process involves navigating global supply chains characterized by regional manufacturing hubs, patent considerations, and geopolitical influences. As such, identifying dependable suppliers is a strategic step for pharmaceutical firms aiming for operational resilience.

Key Suppliers and Manufacturers of Neomycin, Polymyxin B Sulfates, and Dexamethasone

1. Major Global Manufacturers of Neomycin

Neomycin, an aminoglycoside antibiotic, is primarily produced by pharmaceutical giants and chemical companies specializing in amino sugar derivatives.

Sun Pharmaceutical Industries Ltd. (India):
A major producer offering high-quality neomycin sulfate that complies with international pharmacopeias. Their extensive distribution network serves markets worldwide.
Hindustan Antibiotics Ltd. (India):
Historically significant in aminoglycoside production, Hindustan Antibiotics supplies neomycin used in both topical and systemic applications, with strict manufacturing standards.
Dr. Reddy’s Laboratories (India):
Offers certified neomycin sulfate, catering to both domestic and global markets, with emphasis on GMP compliance.
Krempex (Korea):
A notable manufacturer of antibiotics, including neomycin derivatives, with high-quality certifications suitable for ophthalmic formulations.
United States-based suppliers (e.g., Sagent Pharmaceuticals):
Limited but reliable sources within the US market, often sourcing from Indian or European manufacturers.

2. Leading Producers of Polymyxin B Sulfates

EuroPharm (European Union):
A prominent supplier of polymyxin B sulfate, adhering to rigorous EU GMP standards; supplies to hospitals and pharmaceutical companies globally.
Sandoz (Novartis):
Offers polymyxin B sulfate formulations and raw materials, with extensive regulatory approvals in multiple jurisdictions.
Shandong Qiaochu Pharmaceutical Co., Ltd. (China):
One of the largest producers globally, exporting polymyxin B sulfate as raw material with competitive pricing.
Mitsubishi Tanabe Pharma Corporation (Japan):
Supplies high-purity polymyxin B, mainly for advanced pharmaceutical formulations.
Hetero Labs (India):
Provides bulk polymyxin B sulfate, meeting international quality standards for ophthalmic and injectable use.

3. Top Suppliers of Dexamethasone

Teva Pharmaceuticals (Israel):
A leader in corticosteroid manufacturing, offering dexamethasone in multiple forms, including ophthalmic solutions.
Mitsubishi Tanabe Pharma:
Supplies pharmaceutical-grade dexamethasone for various therapeutic applications, with a focus on purity and stability.
Sun Pharmaceutical Industries Ltd. (India):
Provides dexamethasone with regulatory approvals for ophthalmic use, adhering to global GMP standards.
Pfizer (USA):
Offers dexamethasone formulations and raw materials, often used in combination therapies.
Lunan Pharmaceutical Group (China):
A significant manufacturer of dexamethasone, exporting to international markets with certifications for pharmaceutical use.

Regulatory and Quality Considerations

Suppliers must ensure compliance with pharmacopeial standards—United States Pharmacopeia (USP), European Pharmacopoeia (EP), or other relevant standards. Quality assurance includes rigorous testing for potency, sterility, endotoxins, and stability, especially crucial for ophthalmic formulations with direct ocular contact.

Pharmaceutical companies should verify supplier certifications, including GMP compliance, ISO certifications, and batch-specific quality certificates. Suppliers integrated within validated global supply networks reduce risks linked to regulatory non-compliance or contamination.

Emerging Trends and Alternative Suppliers

Due to supply chain disruptions caused by geopolitical issues or pandemics, pharmaceutical companies increasingly diversify their supplier base. New entrants from regions such as Southeast Asia and Eastern Europe are gaining prominence. Contract manufacturing organizations (CMOs) also play a significant role in supplementing raw material supply.

Advances in manufacturing technology and quality management are enabling smaller producers to meet regulatory demands, fostering competitive dynamics in the supply chain.

Strategic Sourcing and Risk Management

Effective procurement mandates establishing key supplier relationships, conducting supplier audits, and maintaining stock buffers. Dual sourcing—using suppliers from different regions—mitigates risks related to regional disruptions. Long-term contracts with reputable manufacturers foster stability in supply and pricing.

Importantly, due diligence ensures that suppliers' raw materials are traceable, consistent, and compliant with regulatory standards, preventing market recalls and compliance failures.

Conclusion

Reliable sourcing of Neomycin, Polymyxin B Sulfates, and Dexamethasone entails engaging with established manufacturers globally recognized for quality and regulatory compliance. While Indian, Chinese, and European suppliers dominate the market, diversification remains integral to resilient procurement strategies. Monitoring emerging suppliers and maintaining rigorous quality assessments will be vital for pharmaceutical firms aiming to uphold product integrity and supply chain stability.

Key Takeaways

Major suppliers include Indian firms like Sun Pharma, Hindustan Antibiotics, and Dr. Reddy’s, European companies such as EuroPharm, and Chinese manufacturers like Shandong Qiaochu.
Ensuring suppliers' adherence to GMP and pharmacopeial standards is paramount for ophthalmic applications.
Diversification of supply sources mitigates risks stemming from geopolitical disruptions or pandemics.
Contractual and regulatory diligence guarantees consistent raw material quality, essential for patient safety.
Staying updated with emerging manufacturers and technological advances enhances supply chain resilience.

FAQs

1. How can pharmaceutical companies verify supplier compliance with global quality standards?
They should review supplier certifications (GMP, ISO), audit manufacturing facilities, conduct regular quality audits, and review batch testing reports to ensure adherence to pharmacopeial and regulatory requirements.

2. Are there regional differences in the quality of Neomycin, Polymyxin B Sulfates, and Dexamethasone?
Yes, manufacturing standards can vary by region. European and US suppliers generally adhere to stricter GMP standards; Indian and Chinese suppliers also comply but require thorough quality verification.

3. What are the main risks associated with sourcing raw materials from emerging suppliers?
Potential risks include inconsistent quality, regulatory non-compliance, supply delays, or contamination. Due diligence and ongoing quality assessments are critical.

4. How has global supply chain disruption impacted the availability of these raw materials?
Disruptions have caused shortages, delays, and increased costs. Companies are increasingly diversifying suppliers and establishing stockpiles to mitigate these issues.

5. Is there an increasing trend toward local manufacturing of these compounds?
Yes, some regions aim to develop local manufacturing capabilities to reduce reliance on imports, ensure supply security, and comply with regional regulations.

Sources:
[1] Indian Pharmaceutical Industry Reports, 2022
[2] European Medicines Agency (EMA) Product Guidelines, 2023
[3] U.S. Food & Drug Administration (FDA) Supplier Verification Program, 2022
[4] Global Supply Chain Analysis, WHO, 2023
[5] Industry Market Data, Pharmaceutical Technology Insights, 2023

Suppliers and packagers for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE